Chinese Journal of Nursing ›› 2025, Vol. 60 ›› Issue (22): 2790-2797.DOI: 10.3761/j.issn.0254-1769.2025.22.017

• Evidence Synthesis Research • Previous Articles     Next Articles

Systematic evaluation of patient-reported outcome measures for bladder cancer patients

ZHONG Liyi(), JIA Mingfang, LUO Yingxia()   

  • Received:2025-03-10 Online:2025-11-20 Published:2025-11-13
  • Contact: LUO Yingxia

膀胱癌患者自我报告结局评估工具的系统评价

钟丽怡(), 贾铭芳, 罗迎霞()   

  1. 510282 广州市 南方医科大学珠江医院护理部(钟丽怡,罗迎霞);南方医科大学卫生管理学院(贾铭芳)
  • 通讯作者: 罗迎霞
  • 作者简介:钟丽怡:女,本科(硕士在读),护师,E-mail:1825023875@qq.com
  • 基金资助:
    国家自然科学基金(72304130)

Abstract:

Objective To systematically evaluate the measurement properties and methodological quality of patient-reported outcome measures(PROMs) for bladder cancer patients,providing a basis for selecting high-quality assessment tools in clinical practice. Methods A systematic search of the studies related to PROMs for bladder cancer patients was conducted across such databases as PubMed,MedLine,CINAHL,Cochrane Library,Web of Science,Embase,China Biology Medicine disc(CBMdisc),Wanfang Database,CNKI,and VIP Database.The search timeframe spanned from their database inception to January 2025. Totally 2 researchers independently screened the literature and extracted data. The methodological quality and measurement properties of the included studies were evaluated using the Consensus-based Standards for the Selection of Health Measurement Instruments(COSMIN) risk of bias checklist and quality criteria,and recommendations were formulated based on these assessments. Results Totally 14 studies involving 9 PROMs were included. The Bladder Utility Symptom Scale(BUSS) and Bladder Cancer Index (BCI) were recommended as Grade A. The remaining 7 tools were categorized as Grade B. The cross-cultural validity of tools was not assessed. Conclusion Current PROMs tools for bladder cancer exhibit significant heterogeneity in psychometric properties. Further optimization of development processes,cross-cultural validation,and large-sample studies are needed. BUSS and BCI are the currently optimal tools,but their long-term dynamic monitoring capabilities require further attention.

Key words: Urinary Bladder Neoplasms, Patient Self-Report, Assessment Tools, Measurement Properties, Systematic Evaluation, Evidence-Based Nursing

摘要:

目的 系统评价膀胱癌患者自我报告结局评估工具(patient self-reported outcome measures,PROMs)的测量学属性及方法学质量,为临床实践选择高质量评估工具提供依据。方法 系统检索PubMed、Medline、CINAHL、Cochrane Library、Web of Science、Embase和中国生物医学文献数据库、万方数据库、中国知网及维普数据库中与膀胱癌患者自我报告结局评估工具相关的研究,检索时限为建库至2025年1月。由2名研究者独立进行文献筛选和资料提取,采用基于共识的健康测量工具遴选标准指南偏倚风险清单及其质量标准,评定纳入研究的方法学质量及测量学属性,并形成推荐意见。结果 共纳入14篇研究,涉及9种膀胱癌患者自我报告结局评估工具。膀胱效用症状量表和膀胱癌指数量表被推荐为A级;其余7种评估工具被列为B级。所有评估工具均未评估跨文化效度。结论 现有膀胱癌患者自我报告结局评估工具在心理测量学属性上存在显著异质性,需进一步优化开发流程、跨文化验证及大样本研究。膀胱效用症状量表和膀胱癌指数量表是当前推荐的优选工具,可与其他评估工具联合使用。

关键词: 膀胱肿瘤, 患者自我报告, 评估工具, 测量学属性, 系统评价, 循证护理学